PCI Pharma Services ("PCI" or the "Company"), a world-leading global contract development and manufacturing organization ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

More recently, PCI acquired a 100% stake in Ajinomoto’s fill-finish contracting arm Ajinomoto Althea. The deal, for which ...

PCI Pharma Services, a Philadelphia-based biotherapy-focused contract development and manufacturing organization, has secured an investment co-led by Bain Capital and existing backer Kohlberg.

The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.

Bain Capital and Kohlberg have completed a strategic investment in PCI Pharma Services, according to a news release.

Kohlberg is a leading private equity firm headquartered in Mount Kisco, N.Y., with over 30 years of successful experience partnering with management and companies like PCI Pharma Services.

Kohlberg is a leading private equity firm headquartered in Mount Kisco, N.Y. with over 30 years of successful experience partnering with management and companies like PCI Pharma Services.

Mubadala Investment Company, the Abu Dhabi-based sovereign wealth fund managing a global portfolio, is making a significant reinvestment in PCI Pharma Services (PCI).

Kohlberg is a leading private equity firm headquartered in Mount Kisco, N.Y. with over 30 years of successful experience partnering with management and companies like PCI Pharma Services.